<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37081456</PMID><DateCompleted><Year>2023</Year><Month>04</Month><Day>24</Day></DateCompleted><DateRevised><Year>2023</Year><Month>04</Month><Day>24</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2334</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Apr</Month><Day>20</Day></PubDate></JournalIssue><Title>BMC infectious diseases</Title><ISOAbbreviation>BMC Infect Dis</ISOAbbreviation></Journal><ArticleTitle>Predicting norovirus and rotavirus resurgence in the United States following the COVID-19 pandemic: a mathematical modelling study.</ArticleTitle><Pagination><StartPage>254</StartPage><MedlinePgn>254</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">254</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12879-023-08224-w</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">To reduce the burden from the COVID-19 pandemic in the United States, federal and state local governments implemented restrictions such as limitations on gatherings, restaurant dining, and travel, and recommended non-pharmaceutical interventions including physical distancing, mask-wearing, surface disinfection, and increased hand hygiene. Resulting behavioral changes impacted other infectious diseases including enteropathogens such as norovirus and rotavirus, which had fairly regular seasonal patterns prior to the COVID-19 pandemic. The study objective was to project future incidence of norovirus and rotavirus gastroenteritis as contacts resumed and other NPIs are relaxed.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We fitted compartmental mathematical models to pre-pandemic U.S. surveillance data (2012-2019) for norovirus and rotavirus using maximum likelihood estimation. Then, we projected incidence for 2022-2030 under scenarios where the number of contacts a person has per day varies from70%, 80%, 90%, and full resumption (100%) of pre-pandemic levels.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We found that the population susceptibility to both viruses increased between March 2020 and November 2021. The 70-90% contact resumption scenarios led to lower incidence than observed pre-pandemic for both viruses. However, we found a greater than two-fold increase in community incidence relative to the pre-pandemic period under the 100% contact scenarios for both viruses. With rotavirus, for which population immunity is driven partially by vaccination, patterns settled into a new steady state quickly in 2022 under the 70-90% scenarios. For norovirus, for which immunity is relatively short-lasting and only acquired through infection, surged under the 100% contact scenario projection.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">These results, which quantify the consequences of population susceptibility build-up, can help public health agencies prepare for potential resurgence of enteric viruses.</AbstractText><CopyrightInformation>© 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lappe</LastName><ForeName>Brooke L</ForeName><Initials>BL</Initials><Identifier Source="ORCID">0000-0002-7560-1113</Identifier><AffiliationInfo><Affiliation>Gangarosa Department of Environmental Health, Rollins School of Public Health, Emory University, 1518 Clifton Rd, Atlanta, GA, 30322, USA. blappe@emory.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wikswo</LastName><ForeName>Mary E</ForeName><Initials>ME</Initials><AffiliationInfo><Affiliation>Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kambhampati</LastName><ForeName>Anita K</ForeName><Initials>AK</Initials><AffiliationInfo><Affiliation>Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mirza</LastName><ForeName>Sara A</ForeName><Initials>SA</Initials><AffiliationInfo><Affiliation>Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tate</LastName><ForeName>Jacqueline E</ForeName><Initials>JE</Initials><AffiliationInfo><Affiliation>Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kraay</LastName><ForeName>Alicia N M</ForeName><Initials>ANM</Initials><AffiliationInfo><Affiliation>Department of Kinesiology and Community Health, University of Illinois at Urbana-Champaign, Champaign, IL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lopman</LastName><ForeName>Ben A</ForeName><Initials>BA</Initials><AffiliationInfo><Affiliation>Gangarosa Department of Environmental Health, Rollins School of Public Health, Emory University, 1518 Clifton Rd, Atlanta, GA, 30322, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Epidemiology Department, Rollins School of Public Health, Emory University, Atlanta, GA, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 GM124280</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 MD012428</GrantID><Acronym>MD</Acronym><Agency>NIMHD NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>04</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Infect Dis</MedlineTA><NlmUniqueID>100968551</NlmUniqueID><ISSNLinking>1471-2334</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012401" MajorTopicYN="Y">Rotavirus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005759" MajorTopicYN="Y">Gastroenteritis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029322" MajorTopicYN="Y">Norovirus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012400" MajorTopicYN="Y">Rotavirus Infections</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014780" MajorTopicYN="Y">Viruses</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="Y">Enterovirus Infections</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017250" MajorTopicYN="Y">Caliciviridae Infections</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008962" MajorTopicYN="N">Models, Theoretical</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Mathematical modelling</Keyword><Keyword MajorTopicYN="N">Norovirus</Keyword><Keyword MajorTopicYN="N">Rotavirus</Keyword><Keyword MajorTopicYN="N">Seasonality</Keyword><Keyword MajorTopicYN="N">Surveillance</Keyword><Keyword MajorTopicYN="N">Transmission</Keyword></KeywordList><CoiStatement>Not Applicable.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>9</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>4</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>4</Month><Day>24</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>4</Month><Day>21</Day><Hour>0</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>4</Month><Day>20</Day><Hour>23</Hour><Minute>38</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>4</Month><Day>20</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37081456</ArticleId><ArticleId IdType="pmc">PMC10117239</ArticleId><ArticleId IdType="doi">10.1186/s12879-023-08224-w</ArticleId><ArticleId IdType="pii">10.1186/s12879-023-08224-w</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Department of Defense. Coronavirus Department of Defense Response Timeline 2020 . Available from: https://www.defense.gov/Spotlights/Coronavirus-DOD-Response/Timeline/. [Updated 16 Mar 2020].</Citation></Reference><Reference><Citation>Brooks-Pollock E, Read JM, McLean AR, Keeling MJ, Danon L. Mapping social distancing measures to the reproduction number for COVID-19. Philos Trans R Soc Lond B Biol Sci. 1829;2021(376):20200276.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8165600</ArticleId><ArticleId IdType="pubmed">34053268</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu CY, Berlin J, Kiti MC, Del Fava E, Grow A, Zagheni E, et al. Rapid Review of Social Contact Patterns During the COVID-19 Pandemic. Epidemiology. 2021;32(6):781–791. doi: 10.1097/EDE.0000000000001412.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/EDE.0000000000001412</ArticleId><ArticleId IdType="pmc">PMC8478104</ArticleId><ArticleId IdType="pubmed">34392254</ArticleId></ArticleIdList></Reference><Reference><Citation>Kraay ANM, Han P, Kambhampati AK, Wikswo ME, Mirza SA, Lopman BA. Impact of Nonpharmaceutical Interventions for Severe Acute Respiratory Syndrome Coronavirus 2 on Norovirus Outbreaks: An Analysis of Outbreaks Reported By 9 US States. J Infect Dis. 2021;224(1):9–13. doi: 10.1093/infdis/jiab093.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiab093</ArticleId><ArticleId IdType="pmc">PMC7928764</ArticleId><ArticleId IdType="pubmed">33606027</ArticleId></ArticleIdList></Reference><Reference><Citation>Burnett E, Parashar UD, Winn A, Tate JE. Trends in rotavirus laboratory detections and internet search volume before and after rotavirus vaccine introduction and in the context of the coronavirus disease 2019 pandemic-United States, 2000-2021. J Infect Dis. 2022;226(6):967–74. 10.1093/infdis/jiac062.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9383438</ArticleId><ArticleId IdType="pubmed">35184198</ArticleId></ArticleIdList></Reference><Reference><Citation>Foley DA, Yeoh DK, Minney-Smith CA, Martin AC, Mace AO, Sikazwe CT, et al. The interseasonal resurgence of respiratory syncytial virus in Australian children following the reduction of coronavirus disease 2019–related public health measures. Clin Infect Dis. 2021;73(9):e2829–e2830. doi: 10.1093/cid/ciaa1906.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa1906</ArticleId><ArticleId IdType="pmc">PMC7929151</ArticleId><ArticleId IdType="pubmed">33594407</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruggink LD, Garcia-Clapes A, Tran T, Druce JD, Thorley BR. Decreased incidence of enterovirus and norovirus infections during the COVID-19 pandemic, Victoria, Australia, 2020. Commun Dis Intell. 2021;45. 10.33321/cdi.2021.45.5.</Citation><ArticleIdList><ArticleId IdType="pubmed">33573536</ArticleId></ArticleIdList></Reference><Reference><Citation>Institute for Health Metrics and Evaluation (IHME). COVID-19 Projections. University of Washington. https://covid19.healthdata.org/global?view=total-deaths&amp;tab=trend. [Accessed 2021–11–22].</Citation></Reference><Reference><Citation>Ahmed SM, Hall AJ, Robinson AE, Verhoef L, Premkumar P, Parashar UD, et al. Global prevalence of norovirus in cases of gastroenteritis: a systematic review and meta-analysis. Lancet Infect Dis. 2014;14(8):725–730. doi: 10.1016/S1473-3099(14)70767-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(14)70767-4</ArticleId><ArticleId IdType="pmc">PMC8006533</ArticleId><ArticleId IdType="pubmed">24981041</ArticleId></ArticleIdList></Reference><Reference><Citation>Franco MA, Greenberg HB. Rotaviruses, noroviruses, and other gastrointestinal viruses. Goldman's Cecil Medicine. 2012:2144–7. 10.1016/B978-1-4377-1604-7.00388-2.</Citation></Reference><Reference><Citation>Simmons K, Gambhir M, Leon J, Lopman B. Duration of immunity to norovirus gastroenteritis. Emerg Infect Dis. 2013;19(8):1260. doi: 10.3201/eid1908.130472.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid1908.130472</ArticleId><ArticleId IdType="pmc">PMC3739512</ArticleId><ArticleId IdType="pubmed">23876612</ArticleId></ArticleIdList></Reference><Reference><Citation>Barclay L, Park GW, Vega E, Hall A, Parashar U, Vinjé J, et al. Infection control for norovirus. Clin Microbiol Infect. 2014;20(8):731–740. doi: 10.1111/1469-0691.12674.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1469-0691.12674</ArticleId><ArticleId IdType="pmc">PMC4624335</ArticleId><ArticleId IdType="pubmed">24813073</ArticleId></ArticleIdList></Reference><Reference><Citation>Troeger C, Khalil IA, Rao PC, Cao S, Blacker BF, Ahmed T, et al. Rotavirus Vaccination and the Global Burden of Rotavirus Diarrhea Among Children Younger Than 5 Years. JAMA Pediatr. 2018;172(10):958–965. doi: 10.1001/jamapediatrics.2018.1960.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapediatrics.2018.1960</ArticleId><ArticleId IdType="pmc">PMC6233802</ArticleId><ArticleId IdType="pubmed">30105384</ArticleId></ArticleIdList></Reference><Reference><Citation>Centers for Disease Control and Prevention. Rotavirus. In: Wodi AP, Hamborsky J, Morelli V, Schillie S, editors. Epidemiology and prevention of vaccine-preventable diseases. Washington: Public Health Foundation; 2021. p. 289–99.</Citation></Reference><Reference><Citation>Jonesteller CL, Burnett E, Yen C, Tate JE, Parashar UD. Effectiveness of Rotavirus Vaccination: A Systematic Review of the First Decade of Global Postlicensure Data, 2006–2016. Clin Infect Dis. 2017;65(5):840–850. doi: 10.1093/cid/cix369.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/cix369</ArticleId><ArticleId IdType="pubmed">28444323</ArticleId></ArticleIdList></Reference><Reference><Citation>Velázquez FR, Matson DO, Calva JJ, Guerrero ML, Morrow AL, Carter-Campbell S, et al. Rotavirus Infection in Infants as Protection against Subsequent Infections. N Engl J Med. 1996;335(14):1022–1028. doi: 10.1056/NEJM199610033351404.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM199610033351404</ArticleId><ArticleId IdType="pubmed">8793926</ArticleId></ArticleIdList></Reference><Reference><Citation>Centers for Disease Control and Prevention. CDC WONDER, 2017. http://wonder.cdc.gov. Accessed Nov, 2021.</Citation></Reference><Reference><Citation>Padua RN, Tulang AB. A density dependent epidemiological model for the spread of infectious diseases. Liceo Journal of Higher Education Research. 6(2):1–29.</Citation></Reference><Reference><Citation>Harko T, Lobo FSN, Mak MK. Exact analytical solutions of the Susceptible-Infected-Recovered (SIR) epidemic model and of the SIR model with equal death and birth rates. Appl Math Comput. 2014;236:184–194.</Citation></Reference><Reference><Citation>Leshem E, Wikswo M, Barclay L, Brandt E, Storm W, Salehi E, et al. Effects and clinical significance of GII.4 Sydney norovirus, United States, 2012–2013. Emerg Infect Dis. 2013;19(8):1231–8. doi: 10.3201/eid1908.130458.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid1908.130458</ArticleId><ArticleId IdType="pmc">PMC3739516</ArticleId><ArticleId IdType="pubmed">23886013</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah MP, Wikswo ME, Barclay L, et al. Near real-time surveillance of U.S. norovirus outbreaks by the norovirus sentinel testing and tracking network — United States, August 2009–July 2015. MMWR Morb Mortal Wkly Rep. 2017;66:185–9. 10.15585/mmwr.mm6607a1.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5657847</ArticleId><ArticleId IdType="pubmed">28231235</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopman B, Simmons K, Gambhir M, Vinjé J, Parashar U. Epidemiologic implications of asymptomatic reinfection: a mathematical modeling study of norovirus. Am J Epidemiol. 2014;179(4):507–512. doi: 10.1093/aje/kwt287.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/aje/kwt287</ArticleId><ArticleId IdType="pubmed">24305574</ArticleId></ArticleIdList></Reference><Reference><Citation>Steele MK, Remais JV, Gambhir M, Glasser JW, Handel A, Parashar UD, et al. Targeting pediatric versus elderly populations for norovirus vaccines: a model-based analysis of mass vaccination options. Epidemics. 2016;17:42–49. doi: 10.1016/j.epidem.2016.10.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.epidem.2016.10.006</ArticleId><ArticleId IdType="pmc">PMC5206891</ArticleId><ArticleId IdType="pubmed">27821278</ArticleId></ArticleIdList></Reference><Reference><Citation>Current Population Reports: 1950–2020. U.S. Washington: Census Bureau; 2018. https://www.census.gov/en.html. Accessed 21 Dec 2021.</Citation></Reference><Reference><Citation>Chhabra P, Graaf M, Parra GI, et al. Corrigendum: Updated classification of norovirus genogroups and genotypes. J Gen Virol. 2020;101(8):893. 10.1099/jgv.0.001475.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7641392</ArticleId><ArticleId IdType="pubmed">32854814</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopman B, Vennema H, Kohli E, Pothier P, Sanchez A, Negredo A, et al. Increase in viral gastroenteritis outbreaks in Europe and epidemic spread of new norovirus variant. The lancet. 2004;363(9410):682–688. doi: 10.1016/S0140-6736(04)15641-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(04)15641-9</ArticleId><ArticleId IdType="pubmed">15001325</ArticleId></ArticleIdList></Reference><Reference><Citation>Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases. Vaccination Coverage among Young Children (0 – 35 Months). September 2020. Accessed: December 2021. https://www.cdc.gov/vaccines/imz-managers/coverage/childvaxview/interactive-reports/index.html.</Citation></Reference><Reference><Citation>Heymann D. Control of Communicable Diseases Manual. 20th ed. American Public Health Association; 2015.</Citation></Reference><Reference><Citation>Bernstein DI, Sander DS, Smith VE, Schiff GM, Ward RL. Protection from Rotavirus Reinfection: 2-Year Prospective Study. J Infect Dis. 1991;164(2):277–283. doi: 10.1093/infdis/164.2.277.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/164.2.277</ArticleId><ArticleId IdType="pubmed">1649875</ArticleId></ArticleIdList></Reference><Reference><Citation>Bishop RF, Barnes GL, Cipriani E, Lund JS. Clinical Immunity after Neonatal Rotavirus Infection. N Engl J Med. 1983;309(2):72–76. doi: 10.1056/NEJM198307143090203.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM198307143090203</ArticleId><ArticleId IdType="pubmed">6304516</ArticleId></ArticleIdList></Reference><Reference><Citation>Gladstone BP, Ramani S, Mukhopadhya I, Muliyil J, Sarkar R, Rehman AM, et al. Protective Effect of Natural Rotavirus Infection in an Indian Birth Cohort. N Engl J Med. 2011;365(4):337–346. doi: 10.1056/NEJMoa1006261.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1006261</ArticleId><ArticleId IdType="pmc">PMC3596855</ArticleId><ArticleId IdType="pubmed">21793745</ArticleId></ArticleIdList></Reference><Reference><Citation>Rogawski McQuade ET, Liu J, Kang G, Kosek MN, Lima AAM, Bessong PO, et al. Protection From Natural Immunity Against Enteric Infections and Etiology-Specific Diarrhea in a Longitudinal Birth Cohort. J Infect Dis. 2020;222(11):1858–1868. doi: 10.1093/infdis/jiaa031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiaa031</ArticleId><ArticleId IdType="pmc">PMC7653087</ArticleId><ArticleId IdType="pubmed">31984416</ArticleId></ArticleIdList></Reference><Reference><Citation>Mossong J, Hens N, Jit M, Beutels P, Auranen K, Mikolajczyk R, et al. Social contacts and mixing patterns relevant to the spread of infectious diseases. PLoS Med. 2008;5(3):e74. doi: 10.1371/journal.pmed.0050074.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.0050074</ArticleId><ArticleId IdType="pmc">PMC2270306</ArticleId><ArticleId IdType="pubmed">18366252</ArticleId></ArticleIdList></Reference><Reference><Citation>DeSilva MB, Haapala J, Vazquez-Benitez G, Daley MF, Nordin JD, Klein NP, et al. Association of the COVID-19 pandemic with routine childhood vaccination rates and proportion up to date with vaccinations across 8 US health systems in the vaccine safety datalink. JAMA Pediatr. 2022;176(1):68–77. doi: 10.1001/jamapediatrics.2021.4251.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapediatrics.2021.4251</ArticleId><ArticleId IdType="pmc">PMC8498937</ArticleId><ArticleId IdType="pubmed">34617975</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>